Article
Alpha-blocker, PDE-5 combo doesn't lead to CV events
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Pivotal data for lumasiran in PH1 published in NEJM
Nedosiran explored in primary hyperoxaluria type 3
Enrollment completed in pivotal trial of nedosiran for hyperoxaluria
FDA approves androgen inhibitor for metastatic PCa
Blood test could guide treatment for kidney cancer
BCG for bladder cancer in short supply
Regulatory recap: FDA approvals in urology from the first half of 2025
Top 10 Urology Times videos from the first half of 2025
FDA news recap in urology for Q2 2025
da Vinci 5 Surgical System approved in Europe